Effects of befloxatone, a new potent reversible MAO-A inhibitor, on cortex and striatum monoamines in freely moving rats

J Neural Transm Suppl. 1994:41:349-55. doi: 10.1007/978-3-7091-9324-2_46.

Abstract

Single administration of befloxatone (0.75 mg/kg, i.p.) in the rat increased extracellular levels of DA (+300%) in striatum. In frontal cortex, befloxatone (0.75 mg/kg, i.p.) and nialamide (100 mg/kg, i.p.) increased NA by +100% but did not modify 5HT, whereas pargyline (100 mg/kg i.p.) increased extracellular NA and 5HT by 400 and 600%, respectively. At these doses, befloxatone inhibited totally and selectively MAO-A, pargyline inhibited totally MAO-A and MAO-B. Increases of tissue and extracellular concentrations of NA and 5HT were highest after Pargyline suggesting that both monoamines may be metabolized by MAO-A and MAO-B. Befloxatone and nialamide potentiated the effects of idazoxan (20 mg/kg, i.p.) on extracellular NA in frontal cortex, which increased from 350% to 2,000 and 1,500% respectively. These results suggest that alpha 2-adrenoceptors play a major role in the regulation of extracellular NA in frontal cortex.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Biogenic Monoamines / metabolism*
  • Cerebral Cortex / metabolism*
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism
  • Male
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Nialamide / pharmacology
  • Norepinephrine / metabolism
  • Oxazoles / pharmacology*
  • Pargyline / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Serotonin / metabolism

Substances

  • Biogenic Monoamines
  • Monoamine Oxidase Inhibitors
  • Oxazoles
  • Serotonin
  • befloxatone
  • Pargyline
  • Monoamine Oxidase
  • Nialamide
  • Dopamine
  • Norepinephrine